• Profile
Close
Sign Up / Log In
Journal Summaries
Endocrinology
  Pharmacology/kinetics

Comparative effectiveness and safety of empagliflozin on cardiovascular mortality and morbidity in adults with type 2 diabetes

Annals of Translational Medicine | Dec 11, 2017 Pharmacology/kinetics

Use and effectiveness of a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) in a real-world population with type 2 diabetes: Results from a European, multicentre, retrospective chart review study

Diabetes, Obesity and Metabolism | Dec 08, 2017 Pharmacology/kinetics

Pharmacokinetics and tolerability of semaglutide in subjects with hepatic impairment

Diabetes, Obesity and Metabolism | Dec 08, 2017 Pharmacology/kinetics

Liraglutide and Metformin alone or combined therapy for type 2 diabetes patients complicated with coronary artery disease

Lipids in Health and Disease | Dec 07, 2017 Pharmacology/kinetics

Lower mean blood glucose during short-term intensive insulin therapy is associated with long-term glycemic remission in patients with newly diagnosed type 2 diabetes: Evidence-based recommendations for standardization

Journal of Diabetes Investigation | Dec 07, 2017 Pharmacology/kinetics

Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: A randomised controlled trial

Diabetes, Obesity and Metabolism | Dec 07, 2017 Pharmacology/kinetics

Initiation of dapagliflozin and treatment-emergent fractures

Diabetes, Obesity and Metabolism | Dec 06, 2017 Pharmacology/kinetics

Effectiveness and tolerability of therapy with exenatide once-weekly vs basal insulin among injectable-naïve elderly or renal impaired patients with type 2 diabetes in the United States

Diabetes, Obesity and Metabolism | Dec 05, 2017 Pharmacology/kinetics

Empagliflozin decreases remnant-like particle cholesterol in type 2 diabetic patients with insulin resistance

Journal of Diabetes Investigation | Dec 01, 2017 Pharmacology/kinetics

Randomized, double-blind, placebo-controlled dose-finding study of the dipeptidyl peptidase-4 inhibitor linagliptin in pediatric patients with type 2 diabetes

Pediatric Diabetes | Nov 30, 2017 Pharmacology/kinetics

1 … 110 112 114 … 122
Most read this week
1

Alternative Therapies and Infection Management
Placeholder
2

'Weekend Warrior' Trend: Health Perks for Busy Physicians
Placeholder
3

Pulmonary Embolism: MCQs Challenge
Placeholder
4

Pelvic Floor Disorders: Causes, Diagnosis & Treatment
Placeholder
5

Top Foods to Combat Winter Illness
Placeholder
Bannerimg

A variety of information related to Medicine and Health Care. It's all here.

Select Topic

x
M3 app logo
Choose easy access to M3 India from your mobile!

Add to home

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay